PharmacoEconomics logo Adis International logo

Publisher: Adis International

Volume 23, Number 2, 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Friction-Cost Method as an Alternative to the Human-Capital Approach in Calculating Indirect Costs
pp. 103-104(2)
Author: Adis International Limited

Current Opinion

The Friction-Cost Method: Replacement for Nothing and Leisure for Free?
pp. 105-111(7)
Authors: Brouwer Werner B.F.; Koopmanschap Marc A.

Leading Article

The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project
pp. 113-120(8)
Authors: Gérard de Pouvourville; Ulmann Philippe; Nixon John; Boulenger Stéphanie; Glanville Julie; Drummond Michael

The Case for Stratified Cost-Effectiveness Analysis by Baseline Health-Related QOL: Theory and Sensitivity Analysis
pp. 121-132(12)
Author: Schaafsma Joseph

Original Research Article

Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease
pp. 133-141(9)
Authors: Hay Joel W.; Sterling Kimberly L.

Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs
pp. 143-153(11)
Authors: Jacobs Philip; Ohinmaa Arto; Brady Bruce

Evaluation of the Cost Effectiveness of Escitalopram versus Venlafaxine XR in Major Depressive Disorder
pp. 155-167(13)
Authors: Fernandez José-Luis; Montgomery Stuart; Francois Clément

Cost-Minimisation Analysis of Sivelestat for Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome
pp. 169-181(13)
Authors: Aikawa Naoki; Fujishima Seitaro; Kobayashi Makoto; Matsuoka Shozo; Abiru Taira

The Impact of Anaemia and its Treatment on Employee Disability and Medical Costs
pp. 183-192(10)
Authors: Berndt Ernst; Crown William; Kallich Joel; Long Stacey; Song Xue; Lyman Gary H.

Adis Pharmacoeconomic Drug Evaluation

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease
pp. 193-206(14)
Authors: Plosker Greg L.; Lyseng-Williamson Katherine A.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A